US Stock MarketDetailed Quotes
IGC IGC Pharma
- 0.3790
- +0.0110+2.99%
Close Dec 20 16:00 ET
- 0.3648
- -0.0142-3.75%
Post 19:52 ET
29.35MMarket Cap-1.90P/E (TTM)
0.3790High0.3308Low737.58KVolume0.3650Open0.3680Pre Close261.14KTurnover1.05%Turnover RatioLossP/E (Static)77.45MShares0.909952wk High3.99P/B26.55MFloat Cap0.265052wk Low--Dividend TTM70.04MShs Float71.1000Historical High--Div YieldTTM13.10%Amplitude0.0001Historical Low0.3540Avg Price1Lot Size
About IGC Pharma Company
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Company Profile
SymbolIGC
Company NameIGC Pharma
Listing DateApr 13, 2006
Founded2005
CEOMr. Ram Mukunda
MarketAMEX
Employees67
Fiscal Year Ends03-31
Address10224 Falls Road
CityPotomac
ProvinceMaryland
CountryUnited States of America
Zip Code20854
Phone1-301-983-0998
Websitehttp://www.igcpharma.com
Company Executives
- Name
- Position
- Salary
- Ram Mukunda
- President, Chief Executive Officer and Director
- 1.82M
- Claudia Grimaldi
- Director, Vice President, Principal Financial Officer and Chief Compliance Officer
- 717.00K
- Rohit Goel
- Principal Accounting Officer
- --
- Richard Prins
- Chairman of the Board
- 259.00K
- Terry L. Lierman
- Independent Director
- 49.00K
- James P Moran
- Independent Director
- 185.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data